SARS-CoV-2/influenza A /influenza B

Short Description:

This kit is suitable for in vitro qualitative detection of SARS-CoV-2, influenza A and influenza B nucleic acid of the nasopharyngeal swab and oropharyngeal swab samples which of the people who were suspected infection of SARS-CoV-2, influenza A and influenza B. It also can be used in suspected pneumonia and suspected cluster cases and for qualitative detection and identify of SARS-CoV-2, influenza A and influenza B nucleic acid in nasopharyngeal swab and oropharyngeal swab samples of novel Coronavirus infection in other circumstances.

Send email to us

Product Detail

Product Tags

Product name

HWTS-RT148-SARS-CoV-2/influenza A /influenza B Nucleic Acid Combined Detection Kit (Fluorescence PCR)

Channel

Channel Name	PCR-Mix 1	PCR-Mix 2
FAM Channel	ORF1ab gene	IVA
VIC/HEX Channel	Internal control	Internal control
CY5 Channel	N gene	/
ROX Channel	E gene	IVB

Technical Parameters

Storage	-18℃
Shelf-life	12 months
Specimen Type	nasopharyngeal swabs and oropharyngeal swabs
Target	SARS-CoV-2 three targets ( Orf1ab, N and E genes )/influenza A /influenza B
Ct	≤38
CV	≤10.0%
LoD	SARS-CoV-2：300 Copies/mL influenza A virus：500 Copies/mL influenza B virus：500 Copies/mL
Specificity	a) The cross test results showed that the kit was compatible with human coronavirus SARSr- CoV, MERSr-CoV, HcoV-OC43, HcoV-229E, HcoV-HKU1, HCoV-NL63, respiratory syncytial virus A and B, parainfluenza virus 1, 2 and 3, rhinovirusA, B and C, adenovirus 1, 2, 3, 4, 5, 7 and 55, human metapneumovirus, enterovirus A, B, C and D, human cytoplasmic pulmonary virus, EB virus, measles virus Human cytomegalovirus, rotavirus, norovirus, mumps virus, varicella zoster virus, Mycoplasma pneumoniae, Chlamydia pneumoniae, Legionella, pertussis, Haemophilus influenzae, Staphylococcus aureus, Streptococcus pneumoniae, Streptococcus pyogenes, Klebsiella pneumoniae, Mycobacterium tuberculosis, Aspergillus fumigatus, Candida albicans, Candida glabrata There was no cross reaction between Pneumocystis yersini and Cryptococcus neoformans. b) Anti interference ability: select mucin (60mg/mL), 10% (V/ V) human blood, diphenylephrine (2mg/mL), hydroxymethylzoline (2mg/mL), sodium chloride (containing preservative) (20mg/mL), beclomethasone (20mg/mL), dexamethasone (20mg/mL), flunisone (20μg/mL), triamcinolone acetonide (2mg/mL), budesonide (2mg/mL), mometasone (2mg/mL), fluticasone (2mg/mL), histamine hydrochloride (5mg/mL), α-Interferon (800IU/mL), zanamivir (20mg/mL), ribavirin (10mg/mL), oseltamivir (60ng/mL), pramivir (1mg/mL), lopinavir (500mg/mL), ritonavir (60mg/mL), mupirocin (20mg/mL), azithromycin (1mg/mL), ceprotene (40μg/mL) Meropenem (200mg/mL), levofloxacin (10μg/mL) and tobramycin (0.6mg/mL). The results showed that the interfering substances at the above concentrations had no interference response to the detection results of pathogens.
Applicable Instruments	Applied Biosystems 7500 Real-Time PCR Systems Applied Biosystems 7500 Fast Real-Time PCR Systems SLAN^® -96P Real-Time PCR Systems QuantStudio™ 5 Real-Time PCR Systems LightCycler^® 480 Real-Time PCR system LineGene 9600 Plus Real-Time PCR Detection System MA-6000 Real-Time Quantitative Thermal Cycler BioRad CFX96 Real-Time PCR System BioRad CFX Opus 96 Real-Time PCR System